Biocytogen · 1 day ago
Scientist/Sr. Scientist-Preclinical Antibody Drug Development
Waltham, Massachusetts, United States
Full-time
Onsite
Senior LevelBiocytogen is seeking highly skilled and motivated scientists to join our antibody discovery team. This role is dedicated to optimizing therapeutic antibody binders from our RenBiologics program, which generates an extensive library of therapeutic antibodies targeting thousands of druggable genes.
BiotechnologyHealth CareMedical DeviceTherapeutics
Responsibilities
Select and evaluate therapeutic targets with a strong understanding of MOA, druggability, and delivery options
Design experimental strategies to advance candidates from Biocytogen’s RenBiologics Antibody Binder/Lead Library toward therapeutic development
Drive projects by assembling resources, managing timelines, and ensuring alignment with program objectives
Engineer antibodies to improve affinity, specificity, stability, and manufacturability
Optimize antibodies through advanced molecular designs, such as Fc engineering or bispecific formats
Evaluate lead antibodies for binding, function, and developability, ensuring readiness for preclinical development
Work with discovery, manufacturing, and BD licensing teams to advance and out-license antibody assets
Maintain clear documentation and present findings to internal and external stakeholders
Qualification
Required
Strong understanding of MOA, druggability, and delivery options
Experience in designing experimental strategies for therapeutic development
Project management skills, including assembling resources and managing timelines
Proficiency in antibody engineering techniques to improve affinity, specificity, stability, and manufacturability
Experience with advanced molecular designs, such as Fc engineering or bispecific formats
Ability to evaluate lead antibodies for binding, function, and developability
Experience in collaboration with discovery, manufacturing, and BD licensing teams
Strong documentation skills and ability to present findings to stakeholders
Company
Biocytogen
Biocytogen is a biopharmaceutical company that provides integrated solutions for antibody drug development.
Founded in 2008
1001-5000 employees
H1B Sponsorship
Biocytogen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (10)
2024 (11)
2023 (3)
2022 (4)
2021 (2)
2020 (4)
Funding
Current Stage
Public CompanyTotal Funding
$335.15MKey Investors
CMB International Capital Corporation
2022-09-01IPO
2022-08-19Post Ipo Equity· $49.8M
2021-06-22Series E
Leadership Team
Qingcong Lin
CEO of Biocytogen Boston Corp
Recent News
2025-12-10
2025-12-10
Morningstar.com
2025-12-05
Company data provided by crunchbase